InterCure Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INCR research report →
Companywww.intercure.co
InterCure Ltd. , together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil.
- CEO
- Alexander Rabinovich
- IPO
- 2019
- Employees
- 320
- HQ
- Herzliya, IL
Price Chart
Valuation
- Market Cap
- $46.75M
- P/E
- -3.93
- P/S
- 0.74
- P/B
- 0.36
- EV/EBITDA
- -8.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 21.66%
- Op Margin
- -17.77%
- Net Margin
- -19.47%
- ROE
- -8.77%
- ROIC
- -4.79%
Growth & Income
- Revenue
- $270.20M · 13.13%
- Net Income
- $-35,710,000 · 47.33%
- EPS
- $-0.63 · 55.63%
- Op Income
- $6.73M
- FCF YoY
- 118.64%
Performance & Tape
- 52W High
- $1.77
- 52W Low
- $0.68
- 50D MA
- $0.80
- 200D MA
- $1.17
- Beta
- 1.11
- Avg Volume
- 31.88K
Get TickerSpark's AI analysis on INCR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Michelson Lennie Grinbaum | other | 0 |
| Mar 31, 20 | Michelson Lennie Grinbaum | other | 4,406 |
| Sep 30, 24 | Michelson Lennie Grinbaum | other | 15,000 |
| Sep 30, 24 | Granot Alon Shmuel | other | 15,000 |
| Mar 18, 26 | Rabinovich Alexander | other | 0 |
| Mar 18, 26 | Rabinovich Alexander | other | 0 |
| Mar 18, 26 | Rabinovich Alexander | other | 0 |
| Mar 18, 26 | Rabinovich Alexander | other | 0 |
| Mar 3, 25 | Rabinovich Alexander | other | 2,070,393 |
| Sep 15, 22 | Rabinovich Alexander | other | 460,000 |
Our INCR Coverage
We haven't published any research on INCR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate INCR Report →